Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
European Journal of Nutrition|December 1, 2025
The relationship between the EAT-Lancet dietary pattern and risk of cardiovascular events in patients with established cardiovascular diseaseLukas L F Hoes, Chiara Colizzi, Yvonne T van der Schouw, et al.Circulation|May 4, 2019
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial FibrillationManon C Stam-Slob, Stuart J Connolly, Yolanda van der Graaf, et al.The American Journal of Cardiology|May 23, 2023
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease LocationsPascal M Burger, Aruna D Pradhan, Jannick A N Dorresteijn, et al.Journal of the American College of Cardiology|July 26, 2023
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseasePascal M Burger, Stefan Koudstaal, Arend Mosterd, et al.Thrombosis and Haemostasis|September 20, 2021
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk ScoreMaria A de Winter, Jannick A N Dorresteijn, Walter Ageno, et al.European Heart Journal Open|June 23, 2023
Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysisNadia E Bonekamp, Anne M May, Martin Halle, et al.European Journal of Preventive Cardiology|September 29, 2023
Long-term lifestyle change and risk of mortality and Type 2 diabetes in patients with cardiovascular diseaseNadia E Bonekamp, Frank L J Visseren, Maarten J Cramer, et al.European Journal of Preventive Cardiology|October 4, 2023
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohortTinka J van Trier, Marjolein Snaterse, S Matthijs Boekholdt, et al.European Heart Journal|September 11, 2019
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trialTamar I de Vries, John W Eikelboom, Jackie Bosch, et al.European Journal of Preventive Cardiology|February 14, 2025
Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular diseaseStella Bijkerk, Frank L J Visseren, Manon G van der Meer, et al.Pageof 7